Tomudex (raltitrexed) / Pfizer, AstraZeneca  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tomudex (raltitrexed) / Pfizer, AstraZeneca
APEC, NCT02965248: Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer ( Study)

Recruiting
3
147
RoW
Standard adjuvant systemic chemotherapy, adjuvant oxaliplatin, 5-FU, and leucovorin calcium (mFOLFOX6), adjuvant oxaliplatin and capecitabine (CapeOx), adjuvant 5-FU and leucovorin calcium (sLV5FU2), adjuvant capecitabine (Cape), Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed, Intraperitoneal raltitrexed 3 mg/m2, Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin, I.V. leucovorin calcium 20 mg/m2, I.V. 5-FU 400 mg/m2, Intraperitoneal oxaliplatin 130 mg/m2
Fudan University
Locally Advanced Colorectal Cancer
11/21
11/23
NCT05231382: Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

Recruiting
3
426
RoW
Raltitrexed, oxaliplatin (SALOX) treatment, Oxaliplatin, fluorouracil/leucovorin (FOLFOX) treatment
Sun Yat-sen University
Hepatocellular Carcinoma
02/24
02/25
ChiCTR2000032992: A Phase III Randomized Controlled Trial of Comparison of Survival Benefit of Hepatic Arterial Infusion of Oxaliplatin plus Raltitrexed With Sorafenib for Patients With intermediate- and advanced-stage Hepatocellular Carcinoma

Not yet recruiting
3
130
 
Hepatic Arterial Infusion of Oxaliplatin plus Raltitrexed ;Oral sorafenib
Fujian Cancer Hospital; Fujian Cancer Hospital, Hospital funding
Hepatocellular carcinoma
 
 
NCT05701436: Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Recruiting
3
144
RoW
Oxaliplatin, Doxorubicin, Lobaplatin, Cisplatin, Oxaliplatin, Leucovorin, fluorouracil, Lobaplatin, Raltitrexed
Zhujiang Hospital
Liver, Cancer of, Primary Resectable
01/26
03/26
NCT05766605: Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Recruiting
3
90
RoW
Oxaliplatin, Doxorubicin, Lobaplatin, Cisplatin, Oxaliplatin, Leucovorin, fluorouracil, Lobaplatin, Raltitrexed
Zhujiang Hospital
Hepatocellular Carcinoma Resectable
01/26
01/26

Download Options